Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
75% of Arab Israelis support Arab party joining government coalition post-war, survey reveals - 2The Best Cell phone Brands for Tech Lovers
- 3Iran slams UN nuclear watchdog for failing to condemn Bushehr attacks
- 4Surf Spot Mechanics: Bells Beach
- 5It May Take a Year to Restore Abu Dhabi Aluminum Output, EGA Says
- Somalia set for 'historic' first offshore oil drilling
- Decrease in Home Buy Credits and Home loan Renegotiating Rates: An Outline of Latest things
- Death toll from floods in Afghanistan rises to 61
- Scientists find evidence that an asteroid contains tryptophan
- Why won't NASA's Artemis 2 astronauts land on the moon when they get there?
- The cheap health insurance promoted by Trump officials has this catch
- The wolf supermoon will kick off 2026 with a celestial bang. Here's when and how to see it.
- Motivational Travel Objections for History Buffs
- Portugal among EU countries with the most people working close to 50 hours a week
